{"product_id":"treatment-of-late-onset-syndromes-secondary-to-neuroleptics-update-von-hanen-ben-ammar-jihed-mrizak-ghada-hamdi","title":"TREATMENT OF LATE-ONSET SYNDROMES SECONDARY TO NEUROLEPTICS","description":"\u003cp\u003eRemission rates for late onset syndromes, a serious and disabling side effect of dopamine receptor blocking agents, are low overall. An accurate phenomenological classification of these syndromes is needed to tailor treatment. The recommended treatment options have a low level of evidence. Clozapine has proven to be effective in clinical practice, particularly in cases of resistant schizophrenia and late onset syndrome. Other therapeutic alternatives seem promising.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9786203727098\"\u003e\u003ch3\u003eUPDATE\u003c\/h3\u003e\u003c\/div\u003e","brand":"Libri","offers":[{"title":"Softcover - 9786203727098","offer_id":39466463101021,"sku":"9786203727098","price":39.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/55770c30-f09a-451a-b470-727c9a292de7.jpg?v=1758261620","url":"https:\/\/shop.autorenwelt.de\/products\/treatment-of-late-onset-syndromes-secondary-to-neuroleptics-update-von-hanen-ben-ammar-jihed-mrizak-ghada-hamdi","provider":"Autorenwelt Shop","version":"1.0","type":"link"}